BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33191223)

  • 1. Molecular Docking, Synthesis And Biological Evaluation Of Ergosteryl-Ferulate As A Hmg-Coa Reductase Inhibitor.
    Aziz S; Elfahmi -; Soemardji AA; Sukrasno -
    Pak J Pharm Sci; 2020 May; 33(3):997-1003. PubMed ID: 33191223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking.
    Islam B; Sharma C; Adem A; Aburawi E; Ojha S
    Drug Des Devel Ther; 2015; 9():4943-51. PubMed ID: 26357462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait.
    Iqbal D; Khan MS; Khan MS; Ahmad S; Hussain MS; Ali M
    Lipids Health Dis; 2015 Mar; 14():15. PubMed ID: 25884722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
    Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S
    Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural mechanism for statin inhibition of HMG-CoA reductase.
    Istvan ES; Deisenhofer J
    Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding effect and design of a competitive inhibitory peptide for HMG-CoA reductase through modeling of an active peptide backbone.
    Pak VV; Koo M; Kim MJ; Yun L; Kwon DY
    Bioorg Med Chem; 2008 Feb; 16(3):1309-18. PubMed ID: 17977732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibitions of annonaceous acetogenins on class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae.
    Feng L; Zhou L; Sun Y; Gui J; Wang X; Wu P; Wan J; Ren Y; Qiu S; Wei X; Li J
    Bioorg Med Chem; 2011 Jun; 19(11):3512-9. PubMed ID: 21550257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant 3-Hydroxy 3-Methyl Glutaryl-CoA Reductase from Candida glabrata (Rec-CgHMGR) Obtained by Heterologous Expression, as a Novel Therapeutic Target Model for Testing Synthetic Drugs.
    Andrade-Pavón D; Cuevas-Hernández RI; Trujillo-Ferrara JG; Hernández-Rodríguez C; Ibarra JA; Villa-Tanaca L
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1478-1490. PubMed ID: 28138930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations.
    Son M; Baek A; Sakkiah S; Park C; John S; Lee KW
    PLoS One; 2013; 8(12):e83496. PubMed ID: 24386216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of degradation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase by sterol regulatory element binding protein cleavage-activating protein requires four phenylalanine residues in span 6 of HMG-CoA reductase transmembrane domain.
    Xu L; Simoni RD
    Arch Biochem Biophys; 2003 Jun; 414(2):232-43. PubMed ID: 12781775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IAF, QGF, and QDF Peptides Exhibit Cholesterol-Lowering Activity through a Statin-like HMG-CoA Reductase Regulation Mechanism: In Silico and In Vitro Approach.
    Silva M; Philadelpho B; Santos J; Souza V; Souza C; Santiago V; Silva J; Souza C; Azeredo F; Castilho M; Cilli E; Ferreira E
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-silico HMG-CoA reductase-inhibitory and in-vivo anti-lipidaemic/anticancer effects of carotenoids from Spondias mombin.
    Metibemu DS; Akinloye OA; Akamo AJ; Okoye JO; Omotuyi IO
    J Pharm Pharmacol; 2021 Sep; 73(10):1377-1386. PubMed ID: 34343336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of synthesis, biological assay, and QSAR studies of HMGR inhibitors.
    García I; Fall Y; Gómez G
    Curr Top Med Chem; 2012; 12(8):895-919. PubMed ID: 22352916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and highly potent hypolipidemic activity of alpha-asarone- and fibrate-based 2-acyl and 2-alkyl phenols as HMG-CoA reductase inhibitors.
    Mendieta A; Jiménez F; Garduño-Siciliano L; Mojica-Villegas A; Rosales-Acosta B; Villa-Tanaca L; Chamorro-Cevallos G; Medina-Franco JL; Meurice N; Gutiérrez RU; Montiel LE; Cruz Mdel C; Tamariz J
    Bioorg Med Chem; 2014 Nov; 22(21):5871-82. PubMed ID: 25311563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypolipidemic mechanism of oryzanol components- ferulic acid and phytosterols.
    Bhaskaragoud G; Rajath S; Mahendra VP; Kumar GS; Gopala Krishna AG; Kumar GS
    Biochem Biophys Res Commun; 2016 Jul; 476(2):82-9. PubMed ID: 27179780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in silico studies of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitory activity of the cowpea Gln-Asp-Phe peptide.
    Silva MBCE; Souza CADC; Philadelpho BO; Cunha MMND; Batista FPR; Silva JRD; Druzian JI; Castilho MS; Cilli EM; Ferreira ES
    Food Chem; 2018 Sep; 259():270-277. PubMed ID: 29680054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 3-hydroxy-3-methylglutaryl coenzyme-A reductases from fungi: a proposal as a therapeutic target and as a study model.
    Andrade-Pavón D; Sánchez-Sandoval E; Rosales-Acosta B; Ibarra JA; Tamariz J; Hernández-Rodríguez C; Villa-Tanaca L
    Rev Iberoam Micol; 2014; 31(1):81-5. PubMed ID: 24270073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis.
    Istvan ES; Palnitkar M; Buchanan SK; Deisenhofer J
    EMBO J; 2000 Mar; 19(5):819-30. PubMed ID: 10698924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.
    Zhang QY; Wan J; Xu X; Yang GF; Ren YL; Liu JJ; Wang H; Guo Y
    J Comb Chem; 2007; 9(1):131-8. PubMed ID: 17206841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and quantitative structure-activity relationship study of lepidopteran HMG-CoA reductase inhibitors as selective insecticides.
    Zang YY; Li YM; Yin Y; Chen SS; Kai ZP
    Pest Manag Sci; 2017 Sep; 73(9):1944-1952. PubMed ID: 28247468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.